Comparison of adenosine effects on atrioventricular node reentry and atrioventricular reciprocating tachycardias

J. Kevin Donahue, M. D. David Orias, Ronald D. Berger, Gordon F. Tomaselli, John H. Lawrence, Hugh Calkins

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Adenosine is an established first line therapy for the treatment of narrow complex tachycardias. The two most common etiologies of paroxysmal supraventricular tachycardia (SVT) are atrioventricular node teen try tachycardia (AVNRT) and atrioventricular reciprocating tachycardia (AVRT). Hypothesis: We postulated that adenosine might have different effects on the termination of AVNRT vs. AVRT, and that these differences might assist in the noninvasive differentiation between these diagnoses. Methods: Fifty- nine patients referred for the diagnosis and treatment of SVT were included in the study. All patients had SVT induced during electrophysiology testing, and each patient received adenosine during SVT. The adenosine dose, time to tachycardia termination, and site of tachycardia termination were recorded. Seventeen patients required isoproterenol administration to initiate SVT This subset of patients was compared with those not requiring isoproterenol. Results: There was no statistically significant difference in the adenosine dose or time to tachycardia termination when comparing patients with AVNRT with those with AVRT. All patients with AVNRT had termination of tachycardia in the antegrade direction with final activation in the atria. Patients requiring isoproterenol for tachycardia initiation experienced tachycardia termination significantly faster than those not requiring isoproterenol, although there was no difference in the dose of adenosine required for termination. Conclusion: These data demonstrate that patients with dual AV node physiology and AVNRT do not have altered sensitivity to adenosine compared with patients with AVRT and normal AV nodes. Further investigation wilt be required to determine the clinical utility of the significantly shorter time to tachycardia termination for patients receiving isoproterenol.

Original languageEnglish (US)
Pages (from-to)743-745
Number of pages3
JournalClinical Cardiology
Volume21
Issue number10
DOIs
StatePublished - Jan 1 1998
Externally publishedYes

Fingerprint

Reciprocating Tachycardia
Atrioventricular Node
Tachycardia
Adenosine
Supraventricular Tachycardia
Isoproterenol
Paroxysmal Tachycardia
Electrophysiology

Keywords

  • Adenosine
  • Isoproterenol
  • Supraventricular tachycardia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Comparison of adenosine effects on atrioventricular node reentry and atrioventricular reciprocating tachycardias. / Kevin Donahue, J.; David Orias, M. D.; Berger, Ronald D.; Tomaselli, Gordon F.; Lawrence, John H.; Calkins, Hugh.

In: Clinical Cardiology, Vol. 21, No. 10, 01.01.1998, p. 743-745.

Research output: Contribution to journalArticle

Kevin Donahue, J. ; David Orias, M. D. ; Berger, Ronald D. ; Tomaselli, Gordon F. ; Lawrence, John H. ; Calkins, Hugh. / Comparison of adenosine effects on atrioventricular node reentry and atrioventricular reciprocating tachycardias. In: Clinical Cardiology. 1998 ; Vol. 21, No. 10. pp. 743-745.
@article{680143ffcafd4ed2b30b75ecddc98179,
title = "Comparison of adenosine effects on atrioventricular node reentry and atrioventricular reciprocating tachycardias",
abstract = "Background: Adenosine is an established first line therapy for the treatment of narrow complex tachycardias. The two most common etiologies of paroxysmal supraventricular tachycardia (SVT) are atrioventricular node teen try tachycardia (AVNRT) and atrioventricular reciprocating tachycardia (AVRT). Hypothesis: We postulated that adenosine might have different effects on the termination of AVNRT vs. AVRT, and that these differences might assist in the noninvasive differentiation between these diagnoses. Methods: Fifty- nine patients referred for the diagnosis and treatment of SVT were included in the study. All patients had SVT induced during electrophysiology testing, and each patient received adenosine during SVT. The adenosine dose, time to tachycardia termination, and site of tachycardia termination were recorded. Seventeen patients required isoproterenol administration to initiate SVT This subset of patients was compared with those not requiring isoproterenol. Results: There was no statistically significant difference in the adenosine dose or time to tachycardia termination when comparing patients with AVNRT with those with AVRT. All patients with AVNRT had termination of tachycardia in the antegrade direction with final activation in the atria. Patients requiring isoproterenol for tachycardia initiation experienced tachycardia termination significantly faster than those not requiring isoproterenol, although there was no difference in the dose of adenosine required for termination. Conclusion: These data demonstrate that patients with dual AV node physiology and AVNRT do not have altered sensitivity to adenosine compared with patients with AVRT and normal AV nodes. Further investigation wilt be required to determine the clinical utility of the significantly shorter time to tachycardia termination for patients receiving isoproterenol.",
keywords = "Adenosine, Isoproterenol, Supraventricular tachycardia",
author = "{Kevin Donahue}, J. and {David Orias}, {M. D.} and Berger, {Ronald D.} and Tomaselli, {Gordon F.} and Lawrence, {John H.} and Hugh Calkins",
year = "1998",
month = "1",
day = "1",
doi = "10.1002/clc.4960211009",
language = "English (US)",
volume = "21",
pages = "743--745",
journal = "Clinical Cardiology",
issn = "0160-9289",
publisher = "John Wiley and Sons Inc.",
number = "10",

}

TY - JOUR

T1 - Comparison of adenosine effects on atrioventricular node reentry and atrioventricular reciprocating tachycardias

AU - Kevin Donahue, J.

AU - David Orias, M. D.

AU - Berger, Ronald D.

AU - Tomaselli, Gordon F.

AU - Lawrence, John H.

AU - Calkins, Hugh

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Background: Adenosine is an established first line therapy for the treatment of narrow complex tachycardias. The two most common etiologies of paroxysmal supraventricular tachycardia (SVT) are atrioventricular node teen try tachycardia (AVNRT) and atrioventricular reciprocating tachycardia (AVRT). Hypothesis: We postulated that adenosine might have different effects on the termination of AVNRT vs. AVRT, and that these differences might assist in the noninvasive differentiation between these diagnoses. Methods: Fifty- nine patients referred for the diagnosis and treatment of SVT were included in the study. All patients had SVT induced during electrophysiology testing, and each patient received adenosine during SVT. The adenosine dose, time to tachycardia termination, and site of tachycardia termination were recorded. Seventeen patients required isoproterenol administration to initiate SVT This subset of patients was compared with those not requiring isoproterenol. Results: There was no statistically significant difference in the adenosine dose or time to tachycardia termination when comparing patients with AVNRT with those with AVRT. All patients with AVNRT had termination of tachycardia in the antegrade direction with final activation in the atria. Patients requiring isoproterenol for tachycardia initiation experienced tachycardia termination significantly faster than those not requiring isoproterenol, although there was no difference in the dose of adenosine required for termination. Conclusion: These data demonstrate that patients with dual AV node physiology and AVNRT do not have altered sensitivity to adenosine compared with patients with AVRT and normal AV nodes. Further investigation wilt be required to determine the clinical utility of the significantly shorter time to tachycardia termination for patients receiving isoproterenol.

AB - Background: Adenosine is an established first line therapy for the treatment of narrow complex tachycardias. The two most common etiologies of paroxysmal supraventricular tachycardia (SVT) are atrioventricular node teen try tachycardia (AVNRT) and atrioventricular reciprocating tachycardia (AVRT). Hypothesis: We postulated that adenosine might have different effects on the termination of AVNRT vs. AVRT, and that these differences might assist in the noninvasive differentiation between these diagnoses. Methods: Fifty- nine patients referred for the diagnosis and treatment of SVT were included in the study. All patients had SVT induced during electrophysiology testing, and each patient received adenosine during SVT. The adenosine dose, time to tachycardia termination, and site of tachycardia termination were recorded. Seventeen patients required isoproterenol administration to initiate SVT This subset of patients was compared with those not requiring isoproterenol. Results: There was no statistically significant difference in the adenosine dose or time to tachycardia termination when comparing patients with AVNRT with those with AVRT. All patients with AVNRT had termination of tachycardia in the antegrade direction with final activation in the atria. Patients requiring isoproterenol for tachycardia initiation experienced tachycardia termination significantly faster than those not requiring isoproterenol, although there was no difference in the dose of adenosine required for termination. Conclusion: These data demonstrate that patients with dual AV node physiology and AVNRT do not have altered sensitivity to adenosine compared with patients with AVRT and normal AV nodes. Further investigation wilt be required to determine the clinical utility of the significantly shorter time to tachycardia termination for patients receiving isoproterenol.

KW - Adenosine

KW - Isoproterenol

KW - Supraventricular tachycardia

UR - http://www.scopus.com/inward/record.url?scp=0031666052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031666052&partnerID=8YFLogxK

U2 - 10.1002/clc.4960211009

DO - 10.1002/clc.4960211009

M3 - Article

C2 - 9789695

AN - SCOPUS:0031666052

VL - 21

SP - 743

EP - 745

JO - Clinical Cardiology

JF - Clinical Cardiology

SN - 0160-9289

IS - 10

ER -